Abandoned Prescriptions Are Worth Fighting Over Too?
"As the head of the R&D department, how can you say it's impossible? Why?"
Okada Murao looked at his subordinate with barely suppressed rage.
The R&D director shook his head with a wry smile, "Mr. Okada, this is not a new thing. Many pharmaceutical companies have thought about this, but unfortunately they have all failed."
"From Pfizer and Johnson & Johnson to Takeda Pharmaceutical, Daiichi Sankyo, and so on, they have all tried to find new treatment directions from abandoned prescriptions, but none of them have succeeded."
"Such behavior is highly accidental and cannot be replicated. I believe that even if the Three Purities Ones succeeded, it was just pure luck. They could never be so lucky as to succeed one after another."
As he explained, he thought to himself that his boss must be under too much pressure lately, his mind was muddled, and he was delusional, coming up with such a terrible idea as developing new drugs using discarded prescriptions.
How could he possibly do something that even global pharmaceutical giants can't?
Forcing him to do it would be like killing him.
They even said that if the Three Purities could do it, why couldn't they?
This is obvious. Can just anyone develop Anti-cancer Drug?
If they had that capability, they wouldn't have spent ten years developing something that yielded nothing.
The important thing is that finding new treatment options in abandoned pharmacies is not exactly a remarkable innovation.
In fact, all pharmaceutical companies and laboratories conduct a variety of experiments when developing new drugs in order to confirm as many treatment options as possible.
It's not uncommon for a new drug to encounter setbacks in its original research direction, only to be revitalized by switching to a different research focus.
When applying for market approval, innovative drugs typically submit only a treatment plan for one disease to ensure a safe outcome. They then meticulously design experiments around this goal, sometimes even selecting specific patients to obtain satisfactory experimental data and pass the review of the FDA and other relevant authorities as much as possible.
In such cases, after a drug is launched on the market, new treatment directions are often discovered during treatment, which can then be used for other unrelated diseases.
Even many drugs that have been on the market for many years can still find new treatment directions and re-register patents for new diseases after their patents expire.
The most classic example of this is the repurposing of Aspirin.
This best-selling drug has been used clinically for over 100 years and is known for its significant antipyretic and analgesic effects.
However, it has a serious side effect: it can cause gastrointestinal bleeding and hemolytic Anemia in patients.
In recent years, teams have begun to study its efficacy in anticoagulation and inhibiting platelet aggregation, and have successfully discovered a series of new uses for Aspirin in stroke patients, such as treating Cerebral Thrombosis and preventing Myocardial Infarction.
This can be described as an old tree blossoming again, a successful example of overcoming adversity.
Every pharmaceutical company dreams of discovering new research directions for its drugs before their patents expire.
But it's not a matter of whether or not one wants to do it, but rather whether or not one can do it.
The difficulty is no less than developing a completely new drug, and not every pharmaceutical company can realize its dream.
Luck is important, but ability is even more important.
Only the top ten pharmaceutical companies in the industry have this capability, which not only allows them to continuously develop new drugs, but also to creatively develop new uses for these drugs.
Developing new directions also requires a significant investment of funds for a second round of clinical trials.
Therefore, pharmaceutical companies generally do not act rashly unless the results are as obvious as those of Viagra, in which case they will continue.
Otherwise, it would just be a waste of a lot of money, with no results.
The Eisai Company can't afford to waste so much money now.
The R&D director clearly didn't have much confidence in his department's R&D capabilities.
Discovering new treatment directions from successful new drugs is already difficult enough, let alone finding new treatment directions from abandoned prescriptions.
The two are not comparable in difficulty. The former can be accomplished by multinational giants, while the latter is simply wishful thinking. Unless one is an exceptionally lucky chosen one, it is impossible to achieve.
He didn't want to take on a task that was destined to fail, so he could only try to persuade his boss to give up this unrealistic idea.
Okamoto Murao remained silent, his face turning grim.
After being persuaded by his subordinates with sound reasoning, he finally regained some composure.
As the R&D director said, it is indeed very difficult to discover new treatment directions from abandoned prescriptions.
He wasn't arrogant enough to think that he could easily accomplish what even top pharmaceutical companies couldn't.
If he had enough money, he could certainly take a gamble, but he didn't.
However, he quickly realized what was happening, frowned, and an idea came to him.
Wei Cai doesn't have this ability, but Three Purities does.
Although he didn't know how the other person did it, his intuition told him that the other person could definitely do it.
Otherwise, the perplexing behavior of the other party purchasing large quantities of discarded prescription drugs cannot be explained.
If Wei Kang can't find new opportunities in discarded prescriptions, why is it making such large-scale purchases?
Given this, why couldn't he seek cooperation with the Three Purities Ones through the discarded prescription?
It is said that Pfizer was able to reach a cooperation agreement with Three Purities on Anti-cancer Drug because it provided the most discarded drug formulas, which allowed it to stand out from many bidding competitors.
"We don't have much cash left to use, around one hundred million US dollars."
Okamoto Murao pondered for a moment and said, "This amount of money would definitely be a drop in the ocean if used for developing new drugs, and it would be very difficult. But it would be easier to use it to acquire some discarded drug formulas."
He made up his mind. "I'll quickly contact the pharmaceutical companies we've worked with and buy their discarded prescriptions at high prices. I think they definitely won't refuse such a good deal."
The R&D director was stunned. "Boss, are you still unwilling to give up and still want to compete with Three Purities? This is not a good idea."
"The company's cash flow is already very tight, we can't waste it all on this. Besides, Three Purities is much richer than us now, we can't compete with them at all."
Can't the boss see what happened to those companies that opposed Three Purities before?
Eisai is not what it used to be. How can a struggling pharmaceutical company with an annual revenue of only 2 billion yen compete with Three Purities?
The pharmaceutical industry requires not only technology, but also sufficient funding; those without enough funds simply cannot afford to operate.
The company has no money, no technology, and yet it's wasting money on this kind of thing.
If this continues, bankruptcy is only a matter of time.
Thinking of this, he couldn't help but shudder, and several thoughts flashed through his mind like a revolving lantern.
Should we run away quickly and look for new opportunities?
While there's still time, should I switch to a pharmaceutical company and find a new job?
I wonder if the Three Purities have any plans to recruit people in Sakura Country. Since they can't beat them, why not join them?
While his thoughts were racing, Okamoto Murao was laughing.
"Who said I'm going to compete with Three Purities? I'm planning to use these prescriptions to collaborate with Wei Kang."
"Didn't he want to discard the drug formula? Then I'll collect more of it and collaborate with him to develop a new drug project. Even if I only get 10%, as long as the research and development is successful, it will be at least ten times the profit, or even a hundred times the profit. It's an incredibly profitable venture."
"Isn't my method brilliant? As long as I have enough discarded medicinal formulas, I'm not worried about the Three Purities not cooperating with us. Hahaha~"
Okamoto Murao, his face flushed, laughed triumphantly.
The R&D director was speechless; he really wanted to remind his boss.
If it were really that simple, why haven't so many pharmaceutical companies done it?
He glanced at the boss's grotesque grin, his face contorted in a grimace, and felt a chill run down his spine. He didn't dare utter another sound.
Instead, he lowered his head and answered loudly and respectfully.
"Okay, I got it. I'll do my best."
******
"Someone is buying up discarded drug prescriptions everywhere, and even driving up the purchase price?"
When Wei Kang learned of this news from Anmei, he was quite surprised.
Besides him, there were actually people who wanted to discard the prescription?
He can't control what happens when they buy up abandoned drug prescriptions; there are plenty of pharmaceutical companies in the world, and plenty of companies are willing to sell.
But what's with raising the price? Is this to compete with him?
It's not like no other pharmaceutical company has done this before, trying to emulate Three Purities's approach of making use of waste.
But after they bought it, they found that they couldn't develop any new treatments at all; it was just throwing money away without any results.
If one wants to stop the Three Purities, all they need to do is not sell the medicinal formulas they possess.
Just like Merck, since its Anti-cancer Drug were targeted and sales plummeted, it has never sold anything related to Three Purities.
Buying discarded drug formulas from other pharmaceutical companies at such high prices is only detrimental to oneself and others, benefiting competitors for no reason, and is a completely unprofitable behavior.
Which pharmaceutical company has lost its mind and committed such an outrageous act?
He looked at the details and found that it was a relatively unknown pharmaceutical company.
"Eisai Weicai Pharmaceutical. of Sakura Country?"
"It used to be a pharmaceutical giant in Sakura Country, but now its performance has declined sharply and it can only stick to the domestic market."
Anmei provided a detailed and objective assessment. "They once developed a blockbuster AD drug with very high sales, but under the impact of Three Purities's AD Special Effect Drug, it has declined and completely fallen into obscurity."
"Moreover, this pharmaceutical company has very poor R&D capabilities. It has not launched an innovative drug in nearly ten years, so it is not worth worrying about."
"Perhaps they are unable to face the blows of reality and want to take a desperate gamble, learning from your methods, President Wei, to conduct secondary research and development on some discarded prescriptions in order to find new directions for treatment."
"This is also a clever way to do things. Secondary research and development is always easier and less expensive. It can also avoid some sunk costs, which is a very smart move."
As she spoke, Anmei's speech slowed down, but after two seconds, she suddenly spoke at a rapid pace.
"Something surprising has happened. I just received a call that seems to be from a Sakura Country. They want to speak with you. Would you like me to transfer you?"
Wei Kang raised an eyebrow. Good heavens, speak of the devil and he appears!
He wanted to see what this company, which dared to compete with him and was raising prices everywhere, was up to.
"Take it."
The telephone on the table rang in response.
After the call connected, strange and broken English came through.
"Hello, is this Sanqing Group? I am Okamoto Murao, CEO of Sakura Country Weicai Pharmaceutical."
The voice was extremely obsequious, and Wei Kang quickly pictured a classic image of a smiling, bowing Sakura Country in his mind.
"That's me. What do you need?" Wei Kang said calmly.
Okamoto Murao was overjoyed. It was Wei Kang himself, not one of his subordinates. This was a rare opportunity.
"Mr. Wei, I would like to cooperate with you."
"Our company, Weicai Pharmaceutical, currently has a large number of discarded drug formulas, numbering in the hundreds, all of which have passed Phase I clinical trials."
"I've noticed that you've been acquiring discarded drug formulas, intending to conduct secondary research and development. I wonder if you'd be interested in the formulas I have?"
Okamoto Murao asked with great respect.
Wei Kang was a little confused. So you're buying up discarded prescriptions at high prices because you're planning to become a middleman?
But he's not one to be easily fooled; he won't buy it if the price isn't right.
"I'm quite interested. Are you planning to sell it to me?" he asked curiously.
"No, no, no, Mr. Wei," Okamoto Murao said with a smile, "I went to great lengths to acquire these discarded prescriptions. I've bought all the ones that are currently available on the market, and pharmaceutical companies generally won't sell the rest."
"In other words, even if you try to acquire it from other pharmaceutical companies now, you won't be able to buy it anymore; it's all with me."
Wei Kang sensed something was amiss and said coldly, "What, are you trying to show off in front of me after you've bought it?"
"Mr. Wei, you have misunderstood me," Okamoto Murao said in a respectful tone, continuing slowly.
"I said from the beginning that I wanted to cooperate with Three Purities."
"Of course, I also have my own ideas about how to cooperate. I'd like to use the prescriptions I have to invest in your new drug project. What do you think?"
"Based on drug development costs, Phase I accounts for approximately 30% of the total drug development costs."
"My demands aren't high; just give me 10% of the project shares, and that will be fine."
"Furthermore, if we cooperate, I can help Three Purities expand its market in Sakura Country. As we all know, the pharmaceutical market in Sakura Country is very exclusive, and foreign companies face great obstacles when trying to enter. I can help solve these problems."
"What do you think? Is this enough sincerity?"
Okamoto Murao was full of confidence, feeling that he had already made a huge concession and that Three Purities had no reason to refuse.
Acquiring discarded prescription drugs also requires connections and costs, which he is willing to pay, even at a premium.
Could Sanqing Group itself acquire so many prescriptions?
Not to mention the many pharmaceutical companies in Japan, such as Takeda, Otsuka, Daiichi Sankyo Sakura Country, which would never sell their prescriptions if it weren't for the sake of their compatriots.
At most, Three Purities will use its gene technology patent licensing to exchange some prescriptions with multinational pharmaceutical companies in Western countries, but the number of prescriptions will not be too large.
Among these pharmaceutical companies, Three Purities only has a decent relationship with Pfizer. The other pharmaceutical companies are all competitors, so they certainly wouldn't be willing to invest in their rivals.
He spent hundreds of millions of US dollars on the acquisition, and that was all the investment cost. Even if it were used for new drug research and development, it would be enough to take a 10% stake.
Not to mention, after the cooperation, Three Purities can also enter the Sakura Country market, which accounts for 8% of the global pharmaceutical market and has a scale of hundreds of billions of US dollars.
He essentially held a prescription in one hand and the Sakura Country market in the other, placing them in front of the other person.
How could Wei Kang possibly refuse?
Okamoto Murao squinted his eyes, patiently waiting for Wei Kang's response.
Wei Kang chuckled, "You want to invest in my new drug project with some unwanted junk? Don't you think that's ridiculous?"
"Those discarded drug formulas can be redeveloped in my hands, but that's my skill, what's it to you?"
"You're overthinking it. Why would I want to cooperate with you? Can't I do it myself?"
"Three Purities has no shortage of people, money, or technology. You are not qualified to talk to me about cooperation, let alone share 10% of the shares. It's just wishful thinking and utter nonsense."
He thought the other party was simply outrageous, with some inexplicable confidence, trying to take advantage of him.
"You've been scavenging discarded drug formulas around the world, driving up prices and severely disrupting the market. These formulas were originally meant for me, but you snatched them all up. I haven't even settled accounts with you yet, and you still want to use this to cooperate with me? Are you out of your mind?"
"Those discarded prescriptions are only treasured by you; to me, they mean nothing."
"Since you like them so much, you can keep them all for yourself."
He got angrier and angrier as he talked, and he was very unhappy when he thought about how the other party had raised the price.
With a bang, the phone was hung up.